海外の治験の状況「前立腺癌」での検索結果
167件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Study of Immunotherapy to Treat Advanced Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, United Kingdom, United States
- 2009-03-12
Not recruiting
- Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- Brazil
- 2014-08-29
Not recruiting
- Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer
- Secondary Malignant Neoplasm of Lymph Node;Prostatic Neoplasms;Secondary Malignant Neoplasm of Lymph Node;Prostatic Neoplasms
- Colombia
- 2014-05-13
Authorised
- An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Metastatic castration-resistant prostate cancer (mCRPC) MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Russian Federation, South Africa, Spain, United Kingdom, United States
- 2014-05-13
Recruiting
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- Prostate Cancer
- Argentina, Australia, Belgium, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Korea, Republic of, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slovakia, South Africa, Spain, United Kingdom, United States
- 2016-11-07
Not recruiting
- A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Colombia
- 2016-09-14
Not recruiting
- A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
- Prostatic Neoplasms
- Argentina, Belgium, Brazil, Canada, France, Singapore, Spain, United States
- 2012-07-06
Not recruiting
- Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-12-03
Authorised
- A multinational study to evaluate the safety and effectiveness of enzalutamide in patients whose prostate cancer has not metastasized
- Patients With Nonmetastatic Castration Resistant Prostate Cancer br>MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-07-10
Recruiting
- Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.
- Prostate Cancer;Prostate Adenocarcinoma;Transrectal High Intensity Focused Ultrasound
- Brazil
- 2017-08-09
